Yujia Xu

Guangdong Provincial Key Laboratory Of Protein Modification And Degradation
Guangzhou, 511436, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Rocket propulsion-inspired two-stage nitric oxide-releasing hydrogel for phase-matched therapy of diabetic wounds.

Rocket propulsion-inspired two-stage nitric oxide-releasing hydrogel for phase-matched therapy of diabetic wounds.

Journal: Acta biomaterialia

Published: February 23, 2026

Validation of the specific loss of interest and pleasure scale in non-clinical and clinical populations.

Validation of the specific loss of interest and pleasure scale in non-clinical and clinical populations.

Journal: Frontiers in psychology

Published: September 16, 2025

Folic acid-targeted Mn-doped carbon dots for controlled ROS amplification and FL/MR imaging-guided synergistic Sono-Chemodynamic Cancer therapy.

Folic acid-targeted Mn-doped carbon dots for controlled ROS amplification and FL/MR imaging-guided synergistic Sono-Chemodynamic Cancer therapy.

Journal: Journal of colloid and interface science

Published: April 22, 2025

Bruceine B Displays Potent Antimyeloma Activity by Inducing the Degradation of the Transcription Factor c-Maf.

Bruceine B Displays Potent Antimyeloma Activity by Inducing the Degradation of the Transcription Factor c-Maf.

Journal: ACS pharmacology & translational science

Published: September 05, 2023

RNF6 promotes chronic myelogenous leukemia cell proliferation and migration by stabilizing vimentin via multiple atypical ubiquitinations.

RNF6 promotes chronic myelogenous leukemia cell proliferation and migration by stabilizing vimentin via multiple atypical ubiquitinations.

Journal: Genes & diseases

Published: January 07, 2023

The ubiquitin ligase HERC4 suppresses MafA transcriptional activity triggered by GSK3β in myeloma by atypical K63-linked polyubiquitination.

The ubiquitin ligase HERC4 suppresses MafA transcriptional activity triggered by GSK3β in myeloma by atypical K63-linked polyubiquitination.

Journal: The Journal of biological chemistry

Published: October 16, 2022

Induction of zinc finger protein RNF6 auto-ubiquitination for the treatment of myeloma and chronic myeloid leukemia.

Induction of zinc finger protein RNF6 auto-ubiquitination for the treatment of myeloma and chronic myeloid leukemia.

Journal: The Journal of biological chemistry

Published: June 16, 2022

Inhibition of the Otub1/c-Maf axis by the herbal acevaltrate induces myeloma cell apoptosis.

Inhibition of the Otub1/c-Maf axis by the herbal acevaltrate induces myeloma cell apoptosis.

Journal: Cell communication and signaling : CCS

Published: May 01, 2020

Novel conjugates of endoperoxide and 4-anilinoquinazoline induce myeloma cell apoptosis by inhibiting the IGF1-R/AKT/mTOR signaling pathway.

Novel conjugates of endoperoxide and 4-anilinoquinazoline induce myeloma cell apoptosis by inhibiting the IGF1-R/AKT/mTOR signaling pathway.

Journal: Bioscience trends

Published: March 17, 2020

Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma.

Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma.

Journal: Blood

Published: February 03, 2020

Anti-bacterial and anti-viral nanchangmycin displays anti-myeloma activity by targeting Otub1 and c-Maf.

Anti-bacterial and anti-viral nanchangmycin displays anti-myeloma activity by targeting Otub1 and c-Maf.

Journal: Cell death & disease

Published: January 08, 2020

The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival.

The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival.

Journal: The Journal of biological chemistry

Published: August 19, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026